Near East University, in collaboration with Istanbul, Arel, and Erciyes universities, has patented a new chemical compound with broad potential applications ranging from food and energy to health. This invention, notable for its antioxidant properties, opens the door to innovative applications in many fields, from sustainable energy solutions to cancer research.
Near East University, ranked among the world’s top 500 universities, has added another achievement to its scientific research and innovation efforts. The patent, titled “A Novel Anthraquinone Derivative Compound, Synthesis Method, and Multi-Field Application Potential”, developed jointly by Near East University, Istanbul University, Arel University, and Erciyes University, has been officially registered. The developed anthraquinone derivative is a special chemical compound with high antioxidant properties.
The study, conducted by the Near East University Technology Transfer Office (NERITA) and protected by intellectual property rights, is the product of a long-term R&D process initiated in 2019. The patent demonstrates the successful synthesis of a new anthraquinone derivative chemical compound using an environmentally friendly, economical, and industrially viable method. This invention transcends laboratory research, becoming a technology with commercializable potential across numerous sectors.
Applications ranging from food and energy to healthcare and advanced technologies!
The developed anthraquinone derivative, thanks to its high antioxidant properties, enables preservative applications in the food, textile, and packaging industries to extend the shelf life of products. This aspect offers widespread potential for use across various sectors.
The developed compound possesses electrochemical properties that can be used in lithium-ion batteries, supercapacitors, redox flow cells, and energy conversion systems. This can contribute to the more effective utilization of renewable energy sources and the development of sustainable energy storage solutions.
Another prominent aspect of the study is its potential contributions to the healthcare field. Laboratory studies have shown that the developed anthraquinone derivative shows a suppressive effect, particularly on the proliferation of breast cancer cells. The invention, which is considered to be effective in patient groups resistant to existing treatments and with limited treatment options, is regarded as a promising step in the development of next-generation cancer drugs.
Commenting on the registered patent, Prof. Dr. İrfan Suat Günsel, Chairman of the Board of Trustees of the Near East Enterprises, emphasized that Near East University has adopted the transformation of scientific production into tangible value as a fundamental approach. Noting that the developed compound has a wide range of applications from food to energy, from health to advanced technologies, Prof. Dr. Günsel stated that such studies conducted at the university and registered with a patent demonstrate that science can be transformed into a value that directly impacts the quality of life.
Prof. Dr. Günsel also touched upon the goals of Near East University. Günsel said, “As an institution ranked among the world’s top 500 universities, our goal is to resolutely continue our path with innovative, sustainable, and high value-added scientific projects that support interdisciplinary studies. At the heart of this approach is the idea that science should address the real needs of society, produce solutions that improve quality of life, and that scientific knowledge should be directly transformed into social benefit.”
Prof. Dr. Tamer Şanlıdağ: “Collective intelligence and interdisciplinary studies are the strongest driving forces of scientific production.”
Prof. Dr. Şanlıdağ also stated that Near East University ensures that scientific studies do not remain solely at the theoretical level. Şanlıdağ said, “Multidisciplinary projects, strengthened by inter-university collaborations, accelerate the transformation of knowledge into production and social benefit. This approach is one of the cornerstones of our university’s research and innovation strategy.” Prof. Dr. Şanlıdağ added that they will soon be filing new patent applications, particularly in the field of health.